Delivery Order SPE2DB20D2104-SPE2DB23FU60L
- Not listed
- This federal contract award, valued at $4,590.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,217.88 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. The contract is not designated with any set-aside requirements, indicating open...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has a firm fixed price, a ceiling value of $2,415.07, and an ultimate completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award, valued at $6,255.08, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% Gel-Solution 5ML, a medication used to treat glaucoma. The contract has a completion date of October 20, 2021 and is a Firm Fixed Price Delivery Order. The prime contractor, AmerisourceBergen Drug Corp, is a subsidiary of the parent company Cencora, Inc. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,136.10 firm-fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The award has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,572.92 firm fixed-price delivery order is for the supply of Timolol 0.25% Gel-Solution, a medication used to treat glaucoma. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,833.35 firm fixed price contract is for the delivery of Timolol 0.25% Gel-Solution, a medication used to treat high eye pressure. The contract has an ultimate completion date of April 4, 2024. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Timolol 0.25% Gel-Solution 5ML, a medication used to treat glaucoma. The $15,387.51 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary contracting...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The contract has a firm fixed price of $1,369.92 and a period of performance through May 14, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution 5ML, a medication used to treat certain eye conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,234.37 and a period of performance through April 7, 2025. The contract was awarded on April 4, 2025 and does not have a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU60LDelivery Order
This federal contract award is a delivery order (SPE2DB23FU60L) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,525.25 firm fixed-price contract is for the delivery of 4,561,625,810 units of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has a completion date of July 28, 2023 and was awarded on July 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for the delivery of this medical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 7/27/23 |